Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the ...

When you hear people talk about metastatic breast cancer, what that is, is basically breast cancer that has spread outside of the breast or the surrounding lymph nodes, where it initially starts ...

"Metastatic breast cancer is where breast cancer moves from the origin in the breast through the blood, and through the lymph ...

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...

Olema Oncology plans to start a Phase III trial studying palazestrant with a CDK4/6 inhibitor from Novartis in mid-2025.

The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...

The "Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 10+ ...

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

Barbara O’Brien, MD, discusses the next steps of the phase 2 TBCRC049 study for the treatment of patients with HER2-positive ...

While early-stage breast cancer is frequently treatable and curable, the situation shifts dramatically once the disease ...

ESMO 2024 TDXd Better Than Chemo for HER2-Low Breast Cancer? Trial results suggested the antibody-drug conjugate may be a treatment option for patients with HER2 metastatic breast cancer in whom ...